Please login to the form below
HAS
This page shows the latest HAS news and features for those working in and with pharma, biotech and healthcare.
Socially distanced strategising
For someone like me who studies how strategies and business models evolve, the COVID lockdown has been as exciting as reduced pollution has been to those lepidopterists who study butterflies. ... This change has relatively little impact on explicit
Latest news
-
J&J inks $1bn deal with US for coronavirus vaccine
The US government also has the option to purchase an additional 200 million doses under a subsequent agreement. ... The US has already signed a number of agreements with a range of companies currently developing COVID-19 vaccines.
-
Novartis builds its case for novel MS treatment ofatumumab
Detailed results from phase 3 studies published in NEJM. Novartis has announced that the detailed results from its phase 3 studies of its investigational multiple sclerosis treatment ofatumumab have been published ... The MS market has long been
-
Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer
The safety profile for both therapies was consistent with what has previously been observed in clinical trials. ... Pfizer has not yet revealed the detailed results from the phase 3 Lorbrena study, but said that the full data is due to be presented at an
-
Merck enters agreement with Hanmi for investigational NASH drug
Licensing agreement includes $10m upfront payment. Merck/MSD has reached a licensing agreement with Korea’s Hanmi Pharmaceutical for an investigational GLP-1/glucagon dual receptor agonist for nonalcoholic steatohepatitis (NASH). ... The focus of the
-
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
AbbVie has decided to exit its existing partnership with Voyager Therapeutics for the development of gene therapies for Alzheimer’s and Parkinson’s disease. ... The Cambridge, US-based biotech company did not give a reason why the collaboration with
More from news
Approximately 1 fully matching, plus 7,363 partially matching documents found.
Latest Intelligence
-
Gut instincts lead Takeda to GI pipeline success
the company has amassed more than 500, 000 patient years’ experience over the product’s six years. ... uptake has been much greater than some analysts predicted,” said Asit Parikh, Takeda’s Head, Gastroenterology Therapeutic Area Unit.
-
What’s next? How behavioural science can support pharma’s future
Will it open up new audiences? Digital engagement has also changed for patients: What are they engaging with? ... Asthma is a prime example where adherence has risen significantly. How have behaviours changed?
-
Post-COVID-19 behaviour – the new normal or nothing new?
By Joe Marshall. At this point, it goes without saying that the COVID-19 pandemic has fundamentally altered almost every aspect of our daily lives. ... In fact, many sources suggest that the industry’s renewed emphasis upon digital communications has
-
The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement
Primary among these has been lack of time and previous experience to ensure all key success factors are effectively addressed. ... In general, the main action taken has been to train and coach existing sales field teams to effectively engage remotely.
-
Persuasive technology: designing behaviour change initiatives for digital
Advances in technology, with the advent of AI and machine learning, has made it possible to influence behavioural change in a more personalised way. ... interaction. And while the pharma industry increasingly seeks to provide such services, it has
More from intelligence
Approximately 0 fully matching, plus 1,066 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
She has 30 years’ experience in international regulatory affairs, 18 years of which were in leadership roles. ... Gilead. Gilead has appointed Mark Genovese (pictured above) as senior vice president, inflammation.
-
New faces at HCA, P\S\L Group and Health Unlimited
Health Unlimited. Health Unlimited has appointed its long-serving team member Clare Peck to the new role of managing director. ... Peck has been with Health Unlimited for 11 years, most recently as head of medical educations.
-
Azafaros expands executive team with three senior hires
Kyle Landskroner (pictured above) has been appointed head or preclinical drug development, joining the team from Novartis. ... Also joining the senior team is Ruben Giorgino (pictured above), who has been appointed head of clinical research and
-
Boehringer Ingelheim appoints Andreas Neumann as HR lead
He will also join the company's board ofmanaging directors. Andreas Neumann has been appointed to the board of managing directors at Boehringer Ingelheim, which has also handed him responsibility for
-
EM Imaging appoints new chairman
The Board of Edinburgh Molecular Imaging (EM Imaging) has appointed John Jeans as non-executive chairman. ... Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. .
More from appointments
Approximately 0 fully matching, plus 1,003 partially matching documents found.
Latest from PMHub
-
Virtual Engagement At Porterhouse: Reflections on the past few months
Meeting the ‘face behind the phone’ has helped us to relate to clients and KOLs as individuals outside of their professional lives”. ... The inability to turn around for a quick brainstorm with your team or tap a colleague on the shoulder to ask a
-
Live Webinar: Examining the Interface Between Healthcare & Society
as a hospitalist has motivated him in communicating science and medicine to the public through his own podcast.
-
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. ... The COVID-19 pandemic has exposed even more evidence for health disparities among different ethnic groups.
-
Medical Device Clinical Trials 2020
We hope that while the clinical trial industry has rapidly evolved in response to COVID-19, that this embrace of technology can continue in the future, for a better patient experience. ----------------. ... Adopting virtual reality as a tool for
-
White paper: The impact of COVID-19 on chronic disease management
Therapy Watch, our syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management.
More from PMHub
Approximately 0 fully matching, plus 1,020 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
- Gut instincts lead Takeda to GI pipeline success
- How will the events and exhibitions industry change post-Coronavirus?
- China’s CanSino Biologics reveals phase 2 coronavirus vaccine results
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Roche’s Tecentriq combo scores FDA approval for melanoma
- Socially distanced strategising
- Artificial Intelligence in Digital Therapeutics
- Virtual Reality in Medicine and Clinical Research
- J&J inks $1bn deal with US for coronavirus vaccine
- Novartis builds its case for novel MS treatment ofatumumab
- Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
